Compare Orchid Chemicals with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs PLETHICO PHARMA - Comparison Results

ORCHID PHARMA LTD     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD PLETHICO PHARMA ORCHID PHARMA LTD/
PLETHICO PHARMA
 
P/E (TTM) x -0.5 -1.1 - View Chart
P/BV x 0.1 0.0 702.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA LTD   PLETHICO PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
PLETHICO PHARMA
Mar-14
ORCHID PHARMA LTD/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs194395 49.1%   
Low Rs3531 111.8%   
Sales per share (Unadj.) Rs276.5604.4 45.7%  
Earnings per share (Unadj.) Rs-79.232.5 -243.9%  
Cash flow per share (Unadj.) Rs-43.551.3 -84.7%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.9473.6 11.4%  
Shares outstanding (eoy) m70.4534.08 206.7%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.40.4 117.5%   
Avg P/E ratio x-1.46.6 -22.0%  
P/CF ratio (eoy) x-2.64.2 -63.5%  
Price / Book Value ratio x2.10.5 471.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0677,262 111.1%   
No. of employees `0002.8NA-   
Total wages/salary Rs m2,5271,596 158.3%   
Avg. sales/employee Rs Th6,956.1NM-  
Avg. wages/employee Rs Th902.5NM-  
Avg. net profit/employee Rs Th-1,993.0NM-  
INCOME DATA
Net Sales Rs m19,47720,598 94.6%  
Other income Rs m407386 105.4%   
Total revenues Rs m19,88420,984 94.8%   
Gross profit Rs m1,1032,818 39.1%  
Depreciation Rs m2,519642 392.2%   
Interest Rs m5,2271,593 328.1%   
Profit before tax Rs m-6,236969 -643.9%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125-138 90.5%   
Profit after tax Rs m-5,5801,107 -504.1%  
Gross profit margin %5.713.7 41.4%  
Effective tax rate %2.0-14.3 -14.1%   
Net profit margin %-28.75.4 -533.2%  
BALANCE SHEET DATA
Current assets Rs m11,01418,877 58.3%   
Current liabilities Rs m32,06011,896 269.5%   
Net working cap to sales %-108.133.9 -318.9%  
Current ratio x0.31.6 21.7%  
Inventory Days Days9536 264.0%  
Debtors Days Days34198 17.0%  
Net fixed assets Rs m29,4409,861 298.6%   
Share capital Rs m705341 206.8%   
"Free" reserves Rs m2,04312,331 16.6%   
Net worth Rs m3,80016,139 23.5%   
Long term debt Rs m9,0184,706 191.6%   
Total assets Rs m46,51033,146 140.3%  
Interest coverage x-0.21.6 -12.0%   
Debt to equity ratio x2.40.3 813.9%  
Sales to assets ratio x0.40.6 67.4%   
Return on assets %-0.88.1 -9.3%  
Return on equity %-146.96.9 -2,141.2%  
Return on capital %-3.712.3 -30.4%  
Exports to sales %37.921.4 177.2%   
Imports to sales %22.615.2 148.6%   
Exports (fob) Rs m7,3784,402 167.6%   
Imports (cif) Rs m4,4063,136 140.5%   
Fx inflow Rs m7,5134,402 170.7%   
Fx outflow Rs m5,6493,184 177.4%   
Net fx Rs m1,8651,219 153.0%   
CASH FLOW
From Operations Rs m1,6822,437 69.0%  
From Investments Rs m-9,860-6,265 157.4%  
From Financial Activity Rs m6,6442,490 266.8%  
Net Cashflow Rs m-1,535-1,337 114.8%  

Share Holding

Indian Promoters % 32.3 82.7 39.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 4.3 107.0%  
FIIs % 3.3 5.5 60.0%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 7.5 737.3%  
Shareholders   84,811 10,665 795.2%  
Pledged promoter(s) holding % 54.9 85.7 64.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   FDC LTD.  UNICHEM LAB  WYETH LTD  AJANTA PHARMA  ALEMBIC LTD  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 93 Points Higher; Oil & Gas and Realty Stocks Witness Buying(Closing)

Indian share markets traded on a volatile note throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the oil & gas sector.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 24, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - NATCO PHARMA COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS